Related Experiment Video
Updated: May 22, 2026
09:02
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary delivery
Mercedes Gonzalez-Juarrero1, Lisa K Woolhiser, Elizabeth Brooks
1Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Antimicrobial Agents and Chemotherapy
|May 2, 2012
Summary
This study introduces a new mouse model for testing aerosolized tuberculosis drugs. Aerosol delivery proved effective in reducing lung bacteria, even with lower doses, and isoniazid also impacted spleen bacteria.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Pharmacology
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Effective drug delivery to the lungs is crucial for treating pulmonary TB.
- Novel methods for antituberculosis drug efficacy testing are needed.
Purpose of the Study:
- To develop and validate an experimental murine model for aerosolized antituberculosis drug efficacy testing.
- To compare the efficacy of aerosolized drug delivery with standard methods for treating pulmonary tuberculosis in mice.
Main Methods:
- Development of an experimental murine model for aerosolized drug delivery.
- Intrapulmonary administration of isoniazid, capreomycin, and amikacin via aerosol.
- Infection of mice with Mycobacterium tuberculosis.
- Quantification of pulmonary and splenic bacterial loads.
Main Results:
- Aerosolized delivery of isoniazid, capreomycin, and amikacin demonstrated efficacy in reducing pulmonary Mycobacterium tuberculosis bacterial loads.
- Efficacy was comparable to standard drug delivery methods, despite lower drug concentrations and fewer doses.
- Intrapulmonary delivery of isoniazid also significantly reduced bacterial load in the spleen.
Conclusions:
- The developed murine model is effective for testing aerosolized antituberculosis drug efficacy.
- Aerosolized antituberculosis drug delivery is a viable and potentially more efficient treatment strategy.
- Intrapulmonary drug delivery may offer systemic benefits beyond the lungs, as suggested by isoniazid's effect on splenic bacteria.
